US Bancorp
PBLS

US Bancorp’s Parabilis Medicines Inc PBLS Stock Holding History

US Bancorp’s Portfolio PBLS Stock Details PBLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.65K Buy
+51
New +$1.78K ﹤0.01% 3964

Other funds holding PBLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals Tarrytown, New York $180M AUM 18.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

US Bancorp's PBLS Position: Q3 2026 in Review

US Bancorp opened a new position in Parabilis Medicines Inc (PBLS) in Q3 2026: 51 shares worth $1.65K. The stake represents ﹤0.01% of the portfolio and ranks #3964 among its holdings.

45 funds tracked by Wall St. Rank hold PBLS as of Q3 2026.

  • US Bancorp held 51 shares of Parabilis Medicines Inc worth $1.65K as of Q3 2026.
  • Parabilis Medicines Inc was a new US Bancorp position in Q3 2026.
  • Parabilis Medicines Inc made up ﹤0.01% of US Bancorp's portfolio in Q3 2026, its #3964 holding.
  • 45 funds tracked by Wall St. Rank held Parabilis Medicines Inc as of Q3 2026.

Based on US Bancorp's 13F filing for Q3 2026, filed 5 Nov 2026.